A report released by a federal congressional agency this week found that a review of a U.S. vaccine injury compensation program shows that less than 3 percent of completed claims during the first several years of the COVID-19 pandemic are eligible for reimbursement.
The U.S. Government Accountability Office (GAO) on Dec. 18 said that a review of the Health and Human Services (HHS) Countermeasures Injury Compensation Program (CICP) revealed that it received “a surge of 13,333 COVID-19 claims,” which is about 27 times the number of claims in the first decade of the program’s history.